SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001213900-21-066685
Filing Date
2021-12-21
Accepted
2021-12-21 16:01:09
Documents
4
Group Members
ALEXANDER LINKALTECH ADVANCED MATERIALS AGANDREAS DANNERDELPHI UNTERNEHMENSBERATUNG AKTIENGESELLSCHAFTDEUTSCHE BALATON BIOTECH AGHANSJORG PLAGGEMARSHEIDELBERGER BETEILIGUNGSHOLDING AGMING LE SPORTS AGPHILIPP WIEDMANNRALPH BIENECKROLF BIRKERTSPARTA AGSTRAW

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 15 TO SCHEDULE 13D ea152830-13da15deutsc_bio.htm SC 13D/A 461964
2 JOINT FILING AGREEMENT ea152830ex99-1_bio.htm EX-99.1 20217
3 AGREEMENT ABOUT THE SETTLEMENT OF LITIGATIONS, DATED NOVEMBER 19, 2021, BY AND A ea152830ex99-4_bio.htm EX-99.4 69694
4 GRAPHIC img_001.jpg GRAPHIC 32625
  Complete submission text file 0001213900-21-066685.txt   598938
Mailing Address ZIEGELHAUSER LANDSTRABE 1 HEIDELBERG 2M 691924-0
Business Address ZIEGELHAUSER LANDSTRABE 1 HEIDELBERG 2M 691924-0 49 6221 64727-0
DEUTSCHE BALATON AKTIENGESELLSCHAFT (Filed by) CIK: 0001571071 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A

Mailing Address HEMMELRATHER WEG 201 LEVERKUSEN 2M D-51377
Business Address HEMMELRATHER WEG 201 LEVERKUSEN 2M D-51377 011 49 214 876 00
Biofrontera AG (Subject) CIK: 0001712641 (see all company filings)

IRS No.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90509 | Film No.: 211509113
SIC: 2834 Pharmaceutical Preparations